Astrazeneca

Astrazeneca is a global, science-led biopharmaceutical company headquartered in the United Kingdom. Their research and development focus primarily on oncology, cardiovascular, renal, metabolic, and respiratory therapeutic areas. They provide a range of prescription medicines distributed to patients in the United States, United Kingdom, Australia, and Canada, alongside other international markets. 6 of their formulations are listed here.

Brilinta 90 Mg Tablet

Brilinta 90 Mg Tablet

Reduces the formation of blood clots by preventing platelets from clumping together in your vascular system.

Crestor 10 Mg

Crestor 10 Mg

Reduces bad cholesterol and fats in the blood, supporting heart health and long-term cardiovascular stability.

Crestor 40 Mg

Crestor 40 Mg

Reduces bad cholesterol and inflammation in blood vessels to help lower the risk of cardiovascular events.

Symbicort 160 Turbuhaler

Symbicort 160 Turbuhaler

Addresses airway inflammation and constriction with a dual-acting combination to support easier breathing in chronic respiratory conditions.

Symbicort 320 Turbuhaler

Symbicort 320 Turbuhaler

Controls inflammation and opens airways to facilitate easier breathing and reduce the frequency of respiratory flare-ups.

About Astrazeneca

Astrazeneca operates as a science-driven biopharmaceutical organization with a significant international presence. The company focuses on the discovery, development, and commercialization of prescription medicines for some of the most serious diseases. By targeting specific molecular pathways, the organization aims to address complex conditions within clinical landscapes.

The company maintains a broad operational footprint, conducting research and manufacturing activities that span multiple continents. Their therapeutic focus is concentrated on areas where they have established clinical expertise, particularly in addressing the underlying biological drivers of illness. This research-heavy approach informs the production of their widely recognized pharmaceutical portfolio.

Astrazeneca’s Product Range

The product range available through this platform reflects Astrazeneca’s focus on chronic disease management and specialty care. The catalog includes specialized formulations for cardiovascular health, such as Crestor and Brilinta, which are used in the regulation of lipid levels and the management of blood clotting.

Additionally, the range covers respiratory care through the Symbicort Turbuhaler series, frequently used in the maintenance treatment of asthma and chronic obstructive pulmonary disease. Oncology and endocrine treatments are also represented, specifically through medications like Arimidex, which is utilized in certain breast cancer treatment protocols.

Finding Astrazeneca Products Online

  • Patients across the United States, United Kingdom, Australia, and Canada and similar markets search for Astrazeneca products through online pharmacy directories when researching their prescribed medication’s manufacturer.
  • Many individuals use these listings to confirm the origin of their medication before visiting a local pharmacy or health provider.
  • Users compare different formulations of Astrazeneca products to understand the range of strengths and delivery methods available for their treatment.
  • The directory helps patients identify specific products after receiving a prescription from a qualified physician.

About the Products Listed

The products listed are generic pharmaceutical formulations manufactured by Astrazeneca. Individual products differ in active ingredient, formulation, strength, and intended use. This page is a product catalog — it is not medical advice or an endorsement of specific products. Readers should review individual product labeling and consult a healthcare professional for guidance on which product suits their needs.